Aptevo Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40 (FOR THE TREATMENT OF CANCER)".

Benzinga Newsdesk www.benzinga.com Neutral 93.7%

Neg 0% Neu 93.7% Pos 0%

https://patentcenter.uspto.gov/applications/17634631/ifw/docs

https://x.com/PatentGrants/status/2074946217625493850

Comments

No comments yet. Be the first!